homefeedbacksupportlog on 2-Dec-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

Women's Health
Endometriosis
Female Subfertility & Gynecological Endocrinology
Fertility Regulation
Genomics & Women's Health
Gynecologic Inflammation & Infections
Menopause & Post-Reproductive Women's Health
Menstrual Abnormalities & Abnormal Uterine Bleeding
Pregnancy, Labor, Delivery & Postpartum Care
Psychological Challenges & Issues for Women
Reproductive Immunology
Related Sections
Breast Diseases: Benign & Malignant
Eating Disorders
Gynecological Cancers
HIV Infection & AIDS: Basic Science
HIV Infection & AIDS: Clinical
HIV Infection & AIDS: Vaccines
Immune & Inflammatory Rheumatic Diseases (inc. Arthritis)
Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Obstetrical Anesthesiology
Reproductive Endocrinology
Sexual Dysfunction
Sexually Transmitted Diseases (without HIV)

profile subject selected for My F1000 Medicine

Browse > Women's Health > Genomics & Women's Health
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 3. Select Page: 1 2 3 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0
Articles that inform your practice or change your way of thinking Changes
Clinical Practice

Confirmation
 Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
Griesshammer M, Struve S, Barbui T
Blood Rev 2008 Sep 22(5):235-45 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Bernard Wittels
Evaluated 8 Oct 2008

Must Read
F1000 Factor 6.0

Confirmation
New Finding
 Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100.
Schneider BP, Wang M, …, Edgerton S, Miller KD
J Clin Oncol 2008 Oct 1 26(28):4672-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Philippe Van Trappen
Evaluated 2 Oct 2008

Recommended
F1000 Factor 3.0

Tech Advance
 A conditional knockout mouse line of the oxytocin receptor.
Lee HJ, Caldwell HK, …, Tolu SG, Young WS
Endocrinology 2008 Jul 149(7):3256-63 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Torsten Reinheimer
Evaluated 16 Sep 2008

Must Read
F1000 Factor 6.0

New Finding
 Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Zhang L, Volinia S, …, Croce CM, Coukos G
Proc Natl Acad Sci U S A 2008 May 13 105(19):7004-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Anna Maria Di Blasio with Davide Gentilini
Evaluated 6 Aug 2008

Recommended
F1000 Factor 3.2

Confirmation
New Finding
Controversial
Refutation
 GPR30 localizes to the endoplasmic reticulum and is not activated by estradiol.
Otto C, Rohde-Schulz B, …, Nubbemeyer R, Fritzemeier KH
Endocrinology 2008 Jun 19 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Steven Young / Valerie Montgomery-Rice with Gloria Richard-Davis
First evaluation 9 Jul 2008 | Latest evaluation 19 Aug 2008

Recommended
F1000 Factor 3.2

New Finding
 The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium.
Cloke B, Huhtinen K, …, Poutanen M, Brosens JJ
Endocrinology 2008 Sep 149(9):4462-74 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Lois Salamonsen / Alistair Williams
First evaluation 9 Jul 2008 | Latest evaluation 25 Sep 2008

Must Read
F1000 Factor 6.0

New Finding
 Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women.
Landau R, Kern C, …, Smiley RM, Blouin JL
Pain 2008 Apr 8 [abstract on PubMed] [related articles] [full text]
Selected by | Brendan Carvalho
Evaluated 23 Jun 2008

Must Read
F1000 Factor 6.0

New Finding
 Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism is a predictive factor of clinical pregnancy after IVF.
Gremlich S, Fratta S, …, Germond M, Gerber S
Hum Reprod 2008 May 23(5):1200-6 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Steven Witkin
Evaluated 18 Jun 2008

Must Read
F1000 Factor 6.0

New Finding
 Stromal gene expression predicts clinical outcome in breast cancer.
Finak G, Bertos N, …, Hallett M, Park M
Nat Med 2008 May 14(5):518-27 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Therese Sørlie
Evaluated 19 May 2008

Recommended
F1000 Factor 3.0

Confirmation
 Prenatal Diagnosis in the First Trimester of Pregnancy.
Ndumbe FM, Navti O, Chilaka VN, Konje JC
Obstet Gynecol Surv 2008 May 63(5):317-328 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Fernando Reis with Quésia Tamara Mirante Ferreira
Evaluated 14 May 2008


top of pagePage 1 of 3. Select Page: 1 2 3 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info